|
|
|
MIRA INFORM REPORT
|
Report No. : |
507556 |
|
Report Date : |
05.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
FRESENIUS MEDICAL CARE INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
S-21, 2nd Floor, Star City, District Centre, Mayur Place,
Mayur Vihar, Phase-1, New Delhi-110091 |
|
Tel. No.: |
91-124-6642500 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
13.03.2006 |
|
|
|
|
Com. Reg. No.: |
55-147436 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 1062.421 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231DL2006FTC147436 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
07AAACF9636N1Z4 |
|
|
|
|
TIN No.: |
07130309588 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACF9636N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the business of Trading of Products and Providing services for the health care industry and for individuals undergoing dialysis. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject was incorporated in the year 2006. It is a subsidiary of Fresenius Medical Care Beteiligungsgesellschaft mbH, Germany. The company is a supplier of equipments, cardio protective, hemodialysis machines and options, hemodialysis and hemofilters, dialysis fluid filters and tubing. As per the financial of 2017, the revenue of the company has increased by 22.32% along with average net profit margin of 6.16%. The company possesses healthy financial position marked by equity infused by its promoters, sound net worth base, debt free balance sheet profile and moderate liquidity position. Rating takes into consideration the strength that the company derives from its holding company and its experienced management team. Rating is however constrained on account of low reserve base. Business is active. Payment seems to be regular. In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 05.05.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
MANAGEMENT NON-COOPERATIVE [91-22-42176500/ 91-9176917181]
[91-124-6642500] Ringing
LOCATIONS
|
Registered Office : |
S-21, 2nd Floor, Star City, District Centre, Mayur Place,
Mayur Vihar, Phase-1, New Delhi-110091 |
|
Tel. No.: |
Not Available |
|
Mobile No.: |
91-9176917181 [Mr. Sanmukha] |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office: |
SAS Tower B, 14th Floor, Sector 38, Gurgaon-122001, Haryana, India |
|
Tel. No.: |
91-124-6642500 |
|
Fax No.: |
91-124-6642506 |
|
|
|
|
Branch Office 1 : |
B-307, Everest Grade, Mahakali Caves Road, Andheri (East),
Mumbai-400093, Maharashtra, India |
|
Tel. No.: |
91-22-42176500 |
|
Telefax No.: |
91-22-42176501 |
|
|
|
|
Branch Office 2 : |
4th Floor, Akash Tower, 781, Anandpur, EM Bypass, Kolkata-700107, West
Bengal, India |
|
Tel. No.: |
91-33-30909500 |
|
Telefax No.: |
91-33-30909506 |
|
|
|
|
Branch Office 3 : |
No.6 and 7, 3rd Floor, Kasi Arcade, 116, Sir Thyagaraya Nagar,
Chennai-600017, Tamilnadu, India |
|
Tel. No.: |
91-44-43960900 |
|
Fax No.: |
91-44-43960915 |
DIRECTORS
AS ON: 31.03.2017
|
Name : |
Andreas Hendrik De Wit |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
Flat B, 29/F, TWR 5, The Austin 8 Wui Cheung Rd, Jordan, Kln, Hong Kong 0000000000 HK |
|||||||||||||
|
Date of Appointment : |
18.07.2016 |
|||||||||||||
|
DIN No.: |
03348093 |
|||||||||||||
|
|
|
|||||||||||||
|
Name : |
Jan Walter |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
No.68, Headland Drive Discovery Bay Lantau New Territories Hong Kong 0000000000 |
|||||||||||||
|
Date of Birth/Age : |
12.08.1975 |
|||||||||||||
|
Qualification : |
MBA |
|||||||||||||
|
Date of Appointment : |
04.06.2015 |
|||||||||||||
|
DIN No.: |
07189614 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Mr. Pankaj Kumar |
|||||||||||||
|
Designation : |
Wholetime Director |
|||||||||||||
|
Address : |
H. No. 43,Ground Floor, Anukampa Apartments Abhay Khand-4, Indirapuram, Shipra Suncity, Ghaziabad-201014, Uttar Pradesh, India |
|||||||||||||
|
Date of Birth/Age : |
15.03.1980 |
|||||||||||||
|
Qualification : |
Chartered Accountant |
|||||||||||||
|
Date of Appointment : |
10.05.2016 |
|||||||||||||
|
PAN No.: |
AMZPK8282F |
|||||||||||||
|
DIN No.: |
07347838 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Mr. Kwong Leung Tsang |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
Flat A 22/F, BLK-1 Illumination Terr 5 Tai Hang Road, Tai Han G Hong Kong 0000000000 |
|||||||||||||
|
Date of Birth/Age : |
03.12.1971 |
|||||||||||||
|
Qualification : |
MBA |
|||||||||||||
|
Date of Appointment : |
10.05.2016 |
|||||||||||||
|
DIN No.: |
07351503 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Mr. Punit Kohli |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
Flat No. 853, Plot No.4, Navsansad Vihar CHS, Dwarka Sector-22, Bagdola, Raj Nagar –II, Delhi 110077, India |
|||||||||||||
|
Date of Birth/Age : |
03.09.1970 |
|||||||||||||
|
Qualification : |
LLB, MBA |
|||||||||||||
|
Date of Appointment : |
10.05.2016 |
|||||||||||||
|
DIN No.: |
07356785 |
|||||||||||||
|
||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Ankur Garg |
|
Designation : |
Company Secretary |
|
Address : |
1/389, First Floor Sector-1, Vaishali, Ghaziabad-201010, Uttar Pradesh, India |
|
Date of Birth/Age : |
02.11.1981 |
|
Qualification : |
Company Secretary |
|
Date of Appointment : |
08.10.2014 |
|
PAN No.: |
ALMPG6478P |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON: 31.03.2017
|
Names of Shareholders |
No. of Shares |
Percentage
of Holding |
|
Fresenius Medical Care Beteilligungsgese IIschaft mbH, Germany |
106108300 |
99.87 |
|
Fresenius Medical Care Deutschland Gmbh, Germany |
133800 |
0.13 |
|
|
|
|
|
Total |
106242100 |
100.00 |
AS ON: 28.09.2017
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters – Body Corporate |
100.00 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the business of Trading of Products and Providing services for the health care industry and for individuals undergoing dialysis. [Registered Activity] |
||||||||
|
|
|
||||||||
|
Products : |
|
||||||||
|
|
|
||||||||
|
Brand Names : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Agencies Held : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Exports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Imports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Terms : |
|
||||||||
|
Selling : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS: NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
|
|
|
Auditors : |
|
|
Name : |
B S R and Associates LLP Chartered Accountants |
|
Address : |
Building No.10, 8th Floor, Tower B, DLF Cyber City, Phase II, Gurgaon-122002, Haryana, India |
|
PAN No.: |
AADFB6889R |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Ultimate
Holding company: |
Fresenius Medical Care AG & Co. KGA |
|
|
|
|
Fellow
Subsidiary company: |
· Fresenius Medical Care Asia-Pacific Limited · Biocare Technology Company Limited · Fresenius Medical Care Technologies Malaysia SDN. BHD. · Fresenius Medical Care Seating (Australia) Pty Ltd · Fresenius Netcare GmbH ·
Fresenius Medical Care Solutions Services
(Philippines), Inc. |
|
|
|
|
Subsidiary
company : |
· Sandor Nephro Services Private Limited [U85100TG2011PTC072032] · Srinath Nephrocare Private Limited [U85100DL2012PTC245524] · Regency Nephrocare Private Limited [U85191UP2013PTC058477] |
CAPITAL STRUCTURE
AS ON: 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
138300000 |
Equity Shares |
INR 10/- each |
INR 1383.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
106242100 |
Equity Shares |
INR 10/- each |
INR 1062.421
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
1062.421 |
122.421 |
122.421 |
|
(b) Reserves and Surplus |
1037.635 |
780.149 |
528.752 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
2100.056 |
902.570 |
651.173 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
2.978 |
|
(c) Other long-term
liabilities |
10.303 |
0.675 |
4.581 |
|
(d) long-term
provisions |
55.447 |
44.832 |
35.467 |
|
Total Non-current
Liabilities (3) |
65.750 |
45.507 |
43.026 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
1489.354 |
1525.325 |
1043.525 |
|
(c) Other
current liabilities |
60.524 |
56.133 |
58.115 |
|
(d) Short-term
provisions |
55.664 |
105.804 |
120.694 |
|
Total Current
Liabilities (4) |
1605.542 |
1687.262 |
1222.334 |
|
|
|
|
|
|
TOTAL |
3771.348 |
2635.339 |
1916.533 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
183.972 |
170.832 |
157.901 |
|
(ii)
Intangible Assets |
2.636 |
3.243 |
3.812 |
|
(iii) Tangible assets capital
work-in-progress |
1.918 |
3.725 |
9.996 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
978.886 |
34.041 |
34.041 |
|
(c) Deferred tax assets (net) |
56.920 |
22.519 |
0.000 |
|
(d)
Long-term loans and advances |
22.622 |
17.348 |
15.806 |
|
(e) Other
Non-current assets |
4.132 |
5.351 |
5.135 |
|
Total Non-Current
Assets |
1251.086 |
257.059 |
226.691 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
1157.465 |
1281.894 |
585.676 |
|
(c) Trade
receivables |
820.621 |
588.659 |
606.189 |
|
(d) Cash and
bank balances |
150.425 |
111.132 |
150.045 |
|
(e)
Short-term loans and advances |
381.923 |
392.307 |
346.039 |
|
(f) Other current
assets |
9.828 |
4.288 |
1.893 |
|
Total
Current Assets |
2520.262 |
2378.280 |
1689.842 |
|
|
|
|
|
|
TOTAL |
3771.348 |
2635.339 |
1916.533 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
4204.870 |
3437.622 |
3205.778 |
|
|
Other Income |
1.004 |
1.390 |
0.629 |
|
|
TOTAL |
4205.874 |
3439.012 |
3206.407 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Purchases of
Stock-in-Trade |
2955.208 |
3112.304 |
2435.416 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
124.429 |
(696.218) |
(5.458) |
|
|
Employee benefit expense |
260.495 |
187.474 |
142.537 |
|
|
Other expenses |
422.232 |
384.777 |
254.581 |
|
|
TOTAL |
3762.364 |
2988.337 |
2827.076 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
443.510 |
450.675 |
379.331 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
3.782 |
10.506 |
10.157 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
439.728 |
440.169 |
369.174 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
50.945 |
45.612 |
41.762 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE
TAX |
388.783 |
394.557 |
327.412 |
|
|
|
|
|
|
|
Less |
TAX |
129.824 |
138.934 |
115.300 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
258.959 |
255.623 |
212.112 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
3.83 |
20.88 |
17.33 |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
333.396 |
210.526 |
187.264 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
124.711 |
21.909 |
128.172 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
71.23 |
62.50 |
69.02 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
5.12 |
5.84 |
5.29 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
183.95 |
178.88 |
156.39 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.38 |
0.35 |
0.65 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
2.35 |
2.53 |
2.21 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.43 |
0.64 |
0.64 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.76 |
1.87 |
1.88 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.09 |
0.20 |
0.26 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
117.27 |
42.90 |
37.35 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
6.16 |
7.44 |
6.62 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
6.87 |
9.70 |
11.07 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
12.33 |
28.32 |
32.57 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.57 |
1.41 |
1.38 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.85 |
0.65 |
0.90 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.56 |
0.34 |
0.34 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.57 |
1.41 |
1.38 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
122.421 |
122.421 |
1062.421 |
|
Reserves & Surplus |
528.752 |
780.149 |
1037.635 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
651.173 |
902.570 |
2100.056 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
0.000 |
0.000 |
0.000 |
|
Debt/Equity
ratio |
0.000 |
0.000 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
3205.778 |
3437.622 |
4204.870 |
|
|
|
7.232 |
22.319 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
3205.778 |
3437.622 |
4204.870 |
|
Profit/ (Loss) |
212.112 |
255.623 |
258.959 |
|
|
6.62
% |
7.44
% |
6.16
% |
LEGAL CASES
CASE DETAILS
Case Type: Cs - CIVIL SUIT
Filing Number: 432/2017Filing
Date: 22-02-2017
Registration Number: 206/2017Registration
Date: 23-02-2017
CNR Number: PBPT02-000402-2017
Case Status
First Hearing
Date: 23rd February 2017
Next Hearing Date: 04th July 2017
Stage of Case: Hearing/Talbi
Court Number and Judge: 3-Additional Civil Judge Senior
Division – 1
Petitioner
and Advocate
1) M/S HOPE HEALTH WAYS
Address - M/S HOPE HEALTH WAYS S. PATEL ENCLAVE,
OPPOSITE KHALSA COLLAGE COLONY, BADUNGAR ROAD, PATIALA THROUGH ITS PARTNER DR.
UPINDER SINGH S/O DR. GURDEEP SINGH
Advocate- Sukhdeep Singh Sahni
2)DR.UPINDER SINGH
M/S HOPE HEALTH WAYS 2. PATEL ENCLAVE, OPPOSITE KHALSA
COLLAGE COLONY, BADUNGAR ROAD, PATIALA
Respondent and Advocate
1) FRESENIUS MEDICAL CARE INDIA PVT LTD.
Address - FRESENTIOUS MEDICAL CARE INDIA PRIVATE LTD.
S-21, SECOND FLOOR STAR CITY, DISTRICT CENTRE MAYUR PLACE, MAYUR VIHAR PHASE -1
, NEW DELHI, THROUGH ITS MANAGER/AUTHORIZED OFFICIAL
2) VISHAL GAKHAR
SENIOR EXECUTIVE OF FERSENIOUS MEDICAL CARE INDIA
PRIVATE , LTD. 2-21 SECOND FLOOR STAR CITY, DISTRICT CENTRE MAYUR PLACE, MAYUR
VIHAR PHASE -1, NEW DELHI.
3) LIFE GUARD MEDICAL SOLUTIONS
LIFE GUARD MEDICAL SOLUTIONS, H.NO. 4, SHOP NO. 15,
PRABHU COMPLEX , SHIVA MARKET , PITAMPURA, DELHI 110034
Acts
|
Under Act(s) |
Under Section(s) |
|
Code of Civil Procedure |
REC |
|
History of Case Hearing |
|
|
Registration Number |
Judge |
Business On Date |
Hearing Date |
Purpose of
hearing |
|
206/2017 |
Additional Civil Judge Senior Division - 1 |
23-02-2017 |
06-04-2017 |
Hearing/Talbi |
|
206/2017 |
Additional Civil Judge Senior Division - 1 |
04-07-2017 |
Hearing/Talbi |
Orders
|
Order Number |
Order Date |
Order Details |
|
1 |
23-02-2017 |
Copy of order |
|
2 |
06-04-2017 |
Copy of order |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
No |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES: NO
CHARGES EXISTS FOR COMPANY
CHANGE OF ADDRESS:
The registered address of the company has been shifted from S-21, 2nd Floor, Star City, Mayur Vihar Phase-1, New Delhi-110092, India to the present address w.e.f. 12.11.2012
BACKGROUND
Subject (‘the Company’) was, incorporated in India on 13 March 2006 as a private limited company. The Company is engaged in the business of trading of products and providing services for the health care industry and for individuals undergoing dialysis.
PERFORMANCE REVIEW
(STANDALONE)
FINANCIAL
PERFORMANCE:
During the financial year, on Standalone basis, the Company's top line evidenced a remarkable upward growth of 22.30% over the previous year as its total income increased to INR 4205.874 Million compared to INR 3439.012 Million for the previous year. Profit for the year recorded as 258.959 Million compared to INR 255.623 Million for the previous year. It is evident from the financial performance that margins have been under pressure due to competition in the medical industry and fluctuation in the rate of foreign exchange despite the fact that revenue from operations have increased considerably by 22% as compare to the previous year.
Based on the robust business model of the Group and the industry projections, going forward, we are confident of achieving decent growth in both top line and bottom line.
BUSINESS PERFORMANCE AND FUTURE OUTLOOK:
During the financial year, the company has achieved income from operation amounting to INR 4204.870 Million which itself is a proof that company is doing well at its existing medical business. With the continuous improvement in economy and living standard in the country and government spending in the End Stage Renal Diseases (ESRD), these present significant growth opportunities for the Company and will allow company to deliver quality services and products to more patients.
Further during financial year under review, the Company has acquired a nationwide dialysis service chain Sparsh Nephrocare operating under Sandor Nephro Services Private Limited. With this acquisition the company has become second largest dialysis service provider in India. Sparsh Nephrocare, with its differentiated business model, is the right platform for the company to establish itself in the under-penetrated Indian market.
Overall the performance of the Company has been good keeping in mind the competitive environment in the healthcare industry. With strong emphasis on resource optimization expecting to yield satisfactory bottom line, we are confident of achieving higher growth in upcoming years for our product as well for service business. The Company is committed to provide quality care to improve quality of life of patients and is well positioned to capture new business potential in the country.
As
part of its vision the Company is committed to be the leading renal care
partner, providing comprehensive and affordable quality care, bringing smiles
to more lives and to improve quality of life of patients.
FIXED ASSETS:
· Plant and equipment
· Furniture and fixtures
· Vehicles
· Office equipment
· Computer equipments
· Leasehold improvements
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 66.77 |
|
UK Pound |
1 |
INR 90.58 |
|
Euro |
1 |
INR 79.97 |
INFORMATION DETAILS
|
Information
Gathered by : |
SHA |
|
|
|
|
Analysis Done by
: |
NIY |
|
|
|
|
Report Prepared
by : |
RUP |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.